Back to search

Jnsf Pharma Limited

14414547

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

UNIT-2, CENTRAL SQUARE SHOPPING CENTRE HIGH STREET, BIRMINGHAM, B23 6RY
Incorporated 12/10/2022

Compliance

Last accounts

31/10/2024

micro entity

Next accounts due

31/07/2026

On track

Confirmation statement

Last: 24/03/2026

Due 07/04/2027

On track

Industry

46460
Wholesale of pharmaceutical goods
47910
Retail sale via mail order houses or via Internet
82920
Packaging activities

Officers

Mr Niju Cheriyan

director · Since 12/10/2022

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 39

Also on 5 other boards

Mr Jaison Thomas Kappikkara

director · Since 12/10/2022

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 51

Also on 6 other boards

Mr Sony Mathew

director · Since 12/10/2022

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 46

Also on 6 other boards

Mrs Sajida Murtaza Raza

director · Since 12/10/2022

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 40

Also on 1 other board

Persons with Significant Control

Mrs Sajida Murtaza Raza

Appoint directors

British · England · Age 40

Unit-2, Central Square Shopping Centre, High Street, Birmingham, B23 6RY

Notified 12/10/2022

Mr Sony Mathew

Appoint directors

British · England · Age 46

Unit-2, Central Square Shopping Centre, High Street, Birmingham, B23 6RY

Notified 12/10/2022

Mr Jaison Thomas Kappikkara

Appoint directors

British · England · Age 51

Unit-2, Central Square Shopping Centre, High Street, Birmingham, B23 6RY

Notified 12/10/2022

Mr Niju Cheriyan

Appoint directors

British · England · Age 39

Unit-2, Central Square Shopping Centre, High Street, Birmingham, B23 6RY

Notified 12/10/2022

CompanyRankvs 705+ SIC 46460 peers
66

Financial strength82th percentile among SIC peers · 21/25
Employees93th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.35× · 12/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Rayburn Trading Company Limited
90
2P & A J Cattee (Wholesale) Ltd.
90
3Hameln Pharma Ltd
90
4Nordic Pharma Limited
90
5Day Lewis Medical Limited
90
6Kinetic Enterprises Limited
90
7Morningside Pharmaceuticals Limited
90
8A1 Pharmaceuticals Public Limited Company
90
9Greiner Bio-One Limited
90
10Trafalgar Scientific Limited
90
705Jnsf Pharma Limited
65
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/10/2025

Net Worth

£224k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£122k

Working capital

Current Assets

£470k

Current Liabilities

£348k

Fixed Assets

£136k

13avg. employees+8

Balance Sheet

Assets less current liabilities£258k
Prepared with BTCSoftware AP Solution 2026 14.1.19

EstimatesDerived

YearCurrent RatioImplied Profit
20251.35+£203k
20240.78+£36k
20230.20—

Derived from filed accounts. Not audited figures.